Skip to content

FR
EN

News
& Events

News
& Events

News
& Events

Latest
releases

National Institutes of Health Notice on Prospective Grant of Exclusive License.

© Inversago 2024

Effective 08 September 2023,
Inversago Pharma is a wholly-owned subsidiary
of Novo Nordisk A/S

Click for
PRESS RELEASE
Click to visit
NOVONORDISK.COM

Voir la version française